Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

Peer Review reports

Original Submission
21 Jun 2022	Submitted	Original manuscript
1 Jul 2022	Reviewed	Reviewer Report - Mahsa Babaei
2 Jul 2022	Reviewed	Reviewer Report
15 Jul 2022	Author responded	Author comments - Anders Ettrup
Resubmission - Version 2
15 Jul 2022	Submitted	Manuscript version 2
Publishing
18 Jul 2022	Editorially accepted
28 Jul 2022	Article published	10.1186/s10194-022-01463-3

Back to article page